beta
ALDX
Aldeyra Therapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.
Market Cap: 142 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.aldeyra.com
Shares Outstanding: 19.1 Million
Float: 18.8 Million
Dividend: 0.0 (0.0%)
Beta: 0.624496
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 375 Thousand
Ethical Flags
Longest drawdown: 920 trading days
From: 2015-01-30 To: 2018-09-25
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|